Central pancreatectomy might be an acceptable surgical procedure for clinical T1 pancreatic body ductal adenocarcinoma: A multicenter retrospective analysis
ConclusionThe clinical outcomes of CP were comparable to or even better than that of conventional pancreatectomy. Our collaborative study suggests that CP may be an acceptable therapeutic option for selected patients with clinical T1 pancreatic body cancer.
Source: Journal of Hepato-Biliary-Pancreatic Surgery - Category: Surgery Authors: Taichi Terai,
Manabu Kawai,
Yuji Kitahata,
Sohei Satoi,
Daisuke Hashimoto,
Minako Nagai,
Satoshi Nishiwada,
Tomohisa Yamamoto,
Hiroki Yamaue,
Masayuki Sho Tags: ORIGINAL ARTICLE Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Insulin | Pancreas | Pancreatic Cancer | Study | Surgery